Uveal disorder
MONDO:0002661A non-neoplastic or neoplastic disorder that affects the uvea. Representative examples include uveitis, chorioretinitis, and uveal melanoma.
Also known as: disease of uvea, disease or disorder of uvea, disorder of uvea, uvea disease, uvea disease or disorder, uveal disease, uveal disorder, uveal tract disease
225 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New trial aims to stop CMV eye inflammation from returning
Disease control Not yet recruitingThis study tests whether oral valganciclovir or ganciclovir eye drops can reduce the virus causing eye inflammation and prevent flare-ups. About 117 adults with CMV anterior uveitis will receive either antiviral treatment or placebo for 7 days, then some continue for 12 months. T…
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a tiny eye implant replace glaucoma drops?
Disease control Not yet recruitingThis trial tests a new device called VividFlo, a small implant placed under the eye's surface to help drain fluid and lower pressure in people with glaucoma. The study involves 10 adults with glaucoma in one eye, who will receive the implant during surgery. Researchers will track…
Phase: NA • Sponsor: VividWhite Pty Ltd • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a single eye injection shrink melanoma and save sight?
Disease control Not yet recruitingThis early-phase trial is testing an investigational drug called RBP-01 (sotrastaurin), given as an injection into the eye, for people with primary uveal melanoma—a rare cancer of the eye. The study aims to see if the drug is safe and whether it can shrink the tumor enough to avo…
Phase: PHASE1, PHASE2 • Sponsor: ReBio Pharma • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a common prostate drug spare the eye during cataract surgery?
Disease control Not yet recruitingThis trial compares two prostate medications, tamsulosin and silodosin, to see how each affects the iris—the colored part of the eye—in men with benign prostatic hyperplasia (BPH). Both drugs can make the iris floppy and the pupil small, which complicates cataract surgery. The st…
Phase: PHASE4 • Sponsor: Mohsen Pourazizi • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could fewer injections keep kids' eye inflammation in check?
Disease control Not yet recruitingThis trial investigates whether children and young adults with juvenile idiopathic arthritis (JIA)-related uveitis can safely take adalimumab injections less frequently without their eye or joint inflammation returning. Participants are assigned to receive injections every 2, 4, …
Phase: PHASE4 • Sponsor: Nisha Acharya • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a simple blood test allow uveitis patients to safely take less medication?
Disease control Not yet recruitingThis trial investigates whether people with chronic non-infectious uveitis—an eye condition that can cause blindness—can safely reduce their dose of adalimumab (a drug that calms the immune system) by using regular blood tests to monitor drug levels. Participants whose uveitis ha…
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can a tiny eye implant tame chronic uveitis Flare-Ups?
Disease control Not yet recruitingThis study will follow 100 adults with non-infectious posterior uveitis, a chronic inflammatory eye disease, who have received a fluocinolone acetonide implant. Researchers will analyze medical records over three years to see how well the implant reduces the frequency and severit…
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
First-in-Class cancer drug targets Hard-to-Treat tumors
Disease control Not yet recruitingThis study tests an experimental oral drug called VMD-102 in people with advanced solid tumors, including liver, lung, kidney, skin (uveal melanoma), and colorectal cancers that have not responded to standard treatments. The drug works by blocking a specific protein (PKC epsilon)…
Phase: PHASE1, PHASE2 • Sponsor: VM Discovery, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could insulin eye drops save your sight? new trial launches
Disease control Not yet recruitingThis study tests whether insulin eye drops can protect the optic nerve in people with open-angle glaucoma. Researchers will give 90 participants either insulin drops or placebo daily for up to 12 months. The main goal is to check safety, but they will also measure vision changes …
Phase: PHASE1, PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New stitch technique aims to prevent dangerous low eye pressure after glaucoma surgery
Disease control Not yet recruitingThis study tests whether placing a temporary stitch inside a tiny drainage device (Preserflo) can reduce the risk of dangerously low eye pressure after glaucoma surgery. The device is already used in France to lower eye pressure, but low pressure can still happen. About 192 adult…
Phase: NA • Sponsor: Hôpital Privé de la Baie • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can a buddy system help seniors with diabetes and forgetfulness take control of their health?
Disease control Not yet recruitingThis study tests whether a 6-week self-management program, done with a caregiver's help, can improve diabetes control and thinking skills in adults aged 55+ who have both diabetes and mild cognitive impairment. About 309 participants will attend weekly group sessions and provide …
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New cell therapy trial aims to tame eye inflammation
Disease control Not yet recruitingThis early-stage study tests a one-time cell therapy called TRX103 for people with active non-infectious uveitis, a condition causing inflammation inside the eye. Up to 18 adults aged 18 to 70 will receive the treatment by IV and be monitored for a year. The main goal is to check…
Phase: PHASE1 • Sponsor: Quan Dong Nguyen • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Laser procedure could offer new hope for pseudoexfoliation glaucoma patients
Disease control Not yet recruitingThis study tests a non-invasive laser procedure called direct selective laser trabeculoplasty (DSLT) in 40 adults with pseudoexfoliation glaucoma. The goal is to see if the laser can safely lower eye pressure by at least 20% at 6 and 12 months. Participants will have their eye pr…
Phase: NA • Sponsor: Vance Thompson Vision • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New drug may curb painful eye flares in arthritis patients
Disease control Not yet recruitingThis study tests whether the drug upadacitinib can reduce how often people with axial spondyloarthritis (a type of arthritis affecting the spine) get sudden eye inflammation (acute anterior uveitis). About 200 adults who have had at least one eye flare in the past year will take …
Phase: PHASE4 • Sponsor: CARE ARTHRITIS LTD. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Immune cells injected into liver or veins to fight advanced melanoma
Disease control Not yet recruitingThis early-stage trial tests whether immune cells taken from a patient's own tumor (TIL) can be safely given directly into the liver or through a vein to fight metastatic melanoma. 18 adults with advanced uveal or cutaneous melanoma that has spread will receive TIL along with che…
Phase: PHASE1 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 26, 2026 19:15 UTC
-
New eye scanner could spot hidden signs of blindness
Diagnosis Not yet recruitingThis study will test a new, non-invasive eye scanner called wide field OCTA in 200 people with various eye diseases, including age-related macular degeneration, diabetic retinopathy, and dry eye. The goal is to see if this device can provide better images of blood vessels in the …
Sponsor: IRCCS San Raffaele • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Could a common steroid prevent a deadly complication in AIDS patients?
Prevention Not yet recruitingThis study tests whether a short course of the steroid prednisolone can prevent paradoxical immune reconstitution inflammatory syndrome (IRIS) in people with AIDS who have low CD4 counts and are starting HIV treatment. About 131 participants will receive either prednisolone or no…
Phase: NA • Sponsor: Shanghai Public Health Clinical Center • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Do common prostate drugs change the eye? a trial investigates
Knowledge-focused Not yet recruitingThis study compares two common prostate medications, tamsulosin and silodosin, to see how they affect pupil size and the thickness of a layer at the back of the eye called the choroid. Men aged 50 and older with benign prostatic hyperplasia (BPH) who have not used these drugs bef…
Phase: PHASE4 • Sponsor: Mohsen Pourazizi • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Can the eye's stiffness predict blurry vision after cataract surgery?
Knowledge-focused Not yet recruitingThis study looks at whether the stiffness of the cornea influences how much astigmatism (blurring from an irregularly shaped cornea) develops after cataract surgery in people with pseudoexfoliation syndrome, a condition that weakens eye tissues. Researchers will measure corneal b…
Sponsor: Kata Culina • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Eye stiffness after cataract surgery: does pseudoexfoliation make a difference?
Knowledge-focused Not yet recruitingThis study follows 70 adults aged 50 and older who are having routine cataract surgery. Half have pseudoexfoliation syndrome, a condition that can weaken eye tissues, and half do not. Researchers measure corneal stiffness before surgery and at several points afterward to see whet…
Sponsor: Kata Culina • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
New eye imaging study aims to map retinal disease progression
Knowledge-focused Not yet recruitingThis observational study will use advanced imaging techniques to measure changes in the retina and choroid (the layer beneath the retina) in people with eye diseases and healthy volunteers. Over 5 years, researchers will track thickness and blood vessel density to better understa…
Sponsor: Fondazione G.B. Bietti, IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Eye drop showdown: could common glaucoma meds save more than sight?
Knowledge-focused Not yet recruitingThis study looks at whether a common type of glaucoma eye drop (prostaglandin analogues) can protect the eye's nerve cells directly, not just by lowering eye pressure. Researchers will review medical records from 1500 adults with glaucoma over 3 years, comparing those on prostagl…
Sponsor: Association for Innovation and Biomedical Research on Light and Image • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
AI to predict anesthesia reactions in new study
Knowledge-focused Not yet recruitingThis study tests a computer program that learns from patient data to predict how the body will respond during anesthesia. Researchers will check if the AI can accurately forecast changes in brain activity and vital signs. 115 adults having planned surgery will take part. The goal…
Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Stick-On neck patch could replace wires for surgery temperature checks
Knowledge-focused Not yet recruitingThis study checks if a small patch placed on the neck can accurately track body temperature during surgery. About 30 adults having planned surgery will wear the patch while standard temperature probes are also used. The goal is to see if the patch matches the accuracy of current …
Sponsor: Murata Vios, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Researchers track Long-Term safety of experimental eye cancer treatment
Knowledge-focused Not yet recruitingThis study is a long-term follow-up for 100 people who completed a previous trial of bel-sar, an experimental treatment for early choroidal melanoma (a type of eye cancer). Participants will not receive any new treatment but will be monitored for about 5 more years to check for s…
Sponsor: Aura Biosciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC